Literature DB >> 21502766

Coronary artery calcification progression is associated with arterial stiffness and cardiac repolarization deterioration in hemodialysis patients.

Biagio Di Iorio1, Onorio Nargi, Emanuele Cucciniello, Vincenzo Bellizzi, Serena Torraca, Domenico Russo, Antonio Bellasi.   

Abstract

BACKGROUND/AIMS: Evidence suggests that vascular calcification (VC) portends poor cardiovascular (CV) prognosis in patients undergoing maintenance dialysis (CKD-5). Nonetheless, how VC might predispose to CV mortality still remains to be clarified. Herein, we report on the association between coronary artery calcification (CAC) progression and changes in cardiac repolarization as well as arterial stiffness.
METHODS: 132 patients new to dialysis were identified. Demographic and clinical characteristics were collected at study entry and during the 12-month follow-up. CAC, 12-lead ECG and pulse wave velocity (PWV) were assessed at baseline and study completion. Uni- and multivariable analyses were applied to detect factors associated with worsening of cardiac repolarization (QTd) and arterial stiffness (PWV).
RESULTS: Uni- and multivariable analyses revealed that CAC progression was associated with a significant increase in both QTd and PWV. Every 20-unit increase in the CAC score corresponded to a significant 23% (95% CI 1.12-1.27; p < 0.001) and 32% (95% CI 1.09-1.37; p < 0.01) increase in the risk of experiencing a 1-m/s increase in PWV and 1 ms in QTd, respectively.
CONCLUSION: VC is a marker of vasculopathy and appears to be associated with cardiac repolarization and arterial stiffness abnormalities in CKD-5 patients.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21502766     DOI: 10.1159/000325656

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  10 in total

1.  QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients.

Authors:  Murat Guney; Abdullah Ozkok; Yasar Caliskan; Hamdi Pusuroglu; Halil Yazici; Savas Tepe; Huseyin Oflaz; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2013-09-14       Impact factor: 2.370

2.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

Review 3.  Coronary artery calcification in chronic kidney disease: An update.

Authors:  Tomasz Stompór
Journal:  World J Cardiol       Date:  2014-04-26

4.  Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage.

Authors:  Antonio Bellasi; Emiliana Ferramosca; Carlo Ratti
Journal:  Int J Nephrol       Date:  2011-05-23

Review 5.  QT interval in CKD and haemodialysis patients.

Authors:  Biagio Di Iorio; Antonio Bellasi
Journal:  Clin Kidney J       Date:  2013-01-17

6.  Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis.

Authors:  Biagio Di Iorio; Lucia Di Micco; Dario Bruzzese; Luca Nardone; Luigi Russo; Pietro Formisano; Vittoria D'Esposito; Domenico Russo
Journal:  J Nephrol       Date:  2017-08-23       Impact factor: 3.902

7.  Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review.

Authors:  Thijs T Jansz; Marianne C Verhaar; Gérard M London; Brigit C van Jaarsveld
Journal:  Clin Kidney J       Date:  2017-10-26

8.  Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.

Authors:  Antonio Bellasi; Paolo Raggi; Jordi Bover; David A Bushinsky; Glenn M Chertow; Markus Ketteler; Mariano Rodriguez; Smeeta Sinha; Carolina Salcedo; Rekha Garg; Alex Gold; Joan Perelló
Journal:  Clin Kidney J       Date:  2019-10-30

9.  The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jeerath Phannajit; Natthaphon Wonghakaeo; Kullaya Takkavatakarn; Thanin Asawavichienjinda; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  J Nephrol       Date:  2021-06-01       Impact factor: 3.902

Review 10.  Mineral metabolic abnormalities and mortality in dialysis patients.

Authors:  Masanori Abe; Kazuyoshi Okada; Masayoshi Soma
Journal:  Nutrients       Date:  2013-03-22       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.